1 s2.0 S1936878X21006215 Main PDF
1 s2.0 S1936878X21006215 Main PDF
1, 2022
ª 2022 THE AUTHORS. PUBLISHED BY ELSEVIER ON BEHALF OF THE AMERICAN
ORIGINAL RESEARCH
KakuyaKitagawa,MD,fRozemarijnVliegenthart,MD,PHD,gMichaelaM.Hell,MD,hJörgHausleiter,MD,i
PatriciaK.Nguyen,MD,j,k,lRicardoP.J.Budde,MD,PHD,a,b KonstantinNikolaou,MD,MBA,m
CezaryKepka,MD,PHD,dRobertManka,MD,nHajimeSakuma,MD,oSachinB.Malik,MD,p,qAdriaanCoenen,MD,a,b
FelixZijlstra,MD,PHD ,bErnstKlotz,DIPLPHYS,rPi mvanderHarst,MD,PHD,s ChristophArtzner,MD,c
AdmirDedic,MD,P,HD,bFrancescaPugliese,MD,PHD,tuFabianBamberg,MD,PHD,v,*KoenNieman,MD,PHDa,b,w,*
ABSTRACT
OBJECTIVES In this international, multicenter study, using third-generation dual-source computed tomography (CT), we
investigated the diagnostic performance of dynamic stress CT myocardial perfusion imaging (CT-MPI) in addition to cor-
onary CT angiography (CTA) compared to invasive coronary angiography (ICA) and invasive fractional flow reserve (FFR).
BACKGROUND CT-MPIcombinedwithcoronaryCTAintegratescoronaryarteryanatomywithinduciblemyocardialischemia,
showing promising results for the diagnosis of hemodynamically significant coronary artery disease in single-center studies.
METHODS At 9 centers in Europe, Japan, and the United States, 132 patients scheduled for ICA were enrolled; 114
patients successfully completed coronary CTA, adenosine-stress dynamic CT-MPI, and ICA. Invasive FFR was performed in
vessels with 25% to 90% stenosis. Data were analyzed by independent core laboratories. For the primary analysis, for
each coronary artery the presence of hemodynamically significant obstruction was interpreted by coronary CTA with CT-
MPI compared to coronary CTA alone, using an FFR of #0.80 and angiographic severity as reference. Territorial absolute
myocardial blood flow (MBF) and relative MBF were compared using C-statistics.
RESULTS ICA and FFR identified hemodynamically significant stenoses in 74 of 289 coronary vessels (26%). Coronary
CTA with $50% stenosis demonstrated a per-vessel sensitivity, specificity, and accuracy for the detection of hemody-
namically significant stenosis of 96% (95% CI: 91%-100%), 72% (95% CI: 66%-78%), and 78% (95% CI: 73%-83%),
respectively. Coronary CTA with CT-MPI showed a lower sensitivity (84%; 95% CI: 75%-92%) but higher specificity
(89%; 95% CI: 85%-93%) and accuracy (88%; 95% CI: 84%-92%). The areas under the receiver-operating characteristic
curve of absolute MBF and relative MBF were 0.79 (95% CI: 0.71-0.86) and 0.82 (95% CI: 0.74-0.88), respectively. The
median dose-length product of CT-MPI and coronary CTA were 313 mGy$cm and 138 mGy$cm, respectively.
CONCLUSIONS Dynamic CT-MPI offers incremental diagnostic value over coronary CTA alone for the identification of
hemodynamically significant coronary artery disease. Generalized results from this multicenter study encourage broader
consideration of dynamic CT-MPI in clinical practice. (Dynamic Stress Perfusion CT for Detection of Inducible Myocardial
Ischemia [SPECIFIC]; NCT02810795) (J Am Coll Cardiol Img 2022;15:75–87) © 2022 The Authors. Published by Elsevier
on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY license
(http://cre ativecommons.org/l icenses/by/4.0/ ).
From the aDepartment of Radiology and Nuclear Medicine, Erasmus University Medical Center, University Medical Center
Rotterdam, Rotterdam, the Netherlands; bDepartment of Cardiology, Erasmus University Medical Center, University Medical
Center Rotterdam, Rotterdam, the Netherlands; cDepartment of Cardiology, University of Tuebingen, Tuebingen, Germany;
d Coronary Disease and Structural Heart Diseases Department, Institute of Cardiology, Warsaw, Poland; eInstitute of Diagnostic
and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; fDepartment of Advanced
Diagnostic Imaging, Mie University Graduate School of Medicine, Tsu, Japan; gDepartment of Radiology, University Medical
Coronarycomputed
ABBREVIATIONS METHODS
AND ACRONYMS
Center Groningen, University of Groningen, Groningen, the Netherlands; hDepartment of Cardiology, Faculty of Medicine, Frie-
drich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; iDepartment of Cardiology, Ludwig-Maximilians University,
Munich, Germany; jVeterans Affairs Palo Alto Healthcare System, Cardiology Section, Palo Alto, California, USA; kStanford Uni-
versity, Division of Cardiovascular Medicine, Stanford, California, USA; lStanford Cardiovascular Institute, Stanford, California,
USA; mDepartment of Radiology, University Hospital of Tübingen, Tübingen, Germany; nDepartment of Cardiology, University
Heart Center and Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich,
Switzerland; oDepartment of Radiology, Mie University Graduate School of Medicine, Tsu, Japan; pVeterans Affairs Palo Alto
Healthcare System, Thoracic and Cardiovascular Imaging Section, Palo Alto, California, USA; qStanford University, Division of
CardiovascularImaging(Affil iated),Stanford,California,USA;rS iemensHealthineers,Forcheim,Germany;sDepartmentofCar-
diology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; tCentre for Advanced Car-
diovascular Imaging, William Harvey Research Institute, Barts National Institute for Health Research Biomedical Research
Centre, Queen Mary University of London, London, United Kingdom; uBarts Heart Centre, St Bartholomew’s Hospital, Barts
Health Na- tionalHealthServiceTrust,WestSmith field,London,UnitedKingdom;vDepartmentofRadiology,MedicalCenter-
Universityof Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; and the wStanford University School of
Medicine and Cardiovascular Institute, Stanford, California, USA. *Dr Bamberg and Dr Nieman contributed equally to this work.
Harvey Hecht, MD, served as Guest Editor for this paper. The authors attest they are in compliance with human studies
committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including
patient consent where appropriate. For more information, visit the Author Center.
Manuscript received March 1, 2021; revised manuscript received July 14, 2021, accepted July 21, 2021.
JACC: CARDIOVASCULAR IMAGING, VOL. 15, NO. 1, 2022 Nous et al
JANUARY 2022:75–87 Diagnostic Performance of Dynamic Perfusion CT
Adenosine - Nitroglycerin
infusion - Beta-blockers
(140 ug/kg/min) (if needed)
B HU HU C
AIF
ml/100 ml/
min 284.1
TAC
Time
(A) Dynamic stress CT-MPI and coronary CTA study protocol. (B) CT-MPI postprocessing: AIF curve and TAC to calculate MBF. (C) CT-MPI
analysis: volumes of interest (circles) placed on a color-coded polar map. AIF
¼ atrial input functional; CT-MPI ¼ computed tomography
myocardial perfusion imaging; CTA ¼ computed tomography angiography; CCTA ¼ coronary computed tomography angiography;
HU ¼ Hounsfield units; MBF ¼ myocardial blood flow; TAC ¼ time-attenuation curve.
and coronary CTA on a third-generation dual-source CT time, 66-ms temporal resolution, and tube voltage of
scanner (SOMATOM Force, Siemens Healthineers) 70-80 kV using the automated exposure control (300
(Figure 1A). Patients were asked to refrain from mAs/rotation at 80 kV as reference). The 3.0-mm-
caffeine-containing beverages for 12 hours and nico- thick slices were reconstructed with 2.0-mm overlap.
tine for 3 hours before the examination. Sublingual CT- MPI data were evaluated at an independent core
lab- oratory (Centre of Advanced Cardiovascular
nitroglycerin was given before coronary CTA, as well as
intravenous beta-blockers if the heart rate was >75 Imaging, Barts Cardiovascular Biomedical Research
beats/min. Center, London, United Kingdom). Image quality was
assessed using a 4-point Likert scale. CT-MPI images
Dynamic stress CT-MPI.Hyperemia was
induced by with poor image quality were excluded from the
intravenous adenosine (140 mg/kg/min) over $3 mi-analysis.
nutes. The standard contrast injection protocol was a Coronary CTA.Coronary CTA scan was acquired
45-mL contrast bolus at 5.5 mL/s (iopromide, Bayer) 5 minutes after CT-MPI using prospective electrocar-
(370 mg/mL), followed by 40 mL saline, with minor diogram-triggered axial or high-pitch spiral scans.
modification at 2 sites because of availability. The CT- Tube current and voltage were (semi)automatically
MPI scan started 4 seconds after contrast injection, selected based on body size. Scan timing was deter-
using alternating table positions (shuttle mode) for mined with a 10-mL contrast test bolus plus 40 mL
complete myocardial coverage. The data set consisted saline or using bolus tracking. For coronary CTA, the
of 10-15 CT data samples over 30 seconds. The cardiac contrast volume was 65 (IQR: 55-75) mL, injected at
rhythm was continuously monitored, and the blood 5.0 (IQR: 4.9-5.4) mL/s with a 40-mL saline bolus
pressure was measured at regular intervals. The CT- chaser. Images were reconstructed with a medium-
MPI scan parameters were as follows: 2 smooth kernel, 0.6-mm slice thickness, and 0.4-mm
96 0.6-
mm collimation resulting in a 105-mm z-axis increment. For 34 patients, adequate-quality coro-
nary CTA was clinically performed within 4 months of
coverage by shuttle mode, 250-ms gantry rotation
Nous et al JACC: CARDIOVASCULAR IMAGING, VOL. 15, NO. 1, 2 0 2 2
F I G U R E 3 Case Examples
A B C D
LCX
LAD
Dg
LAD
LAD
E F G H
J K L M
LCX
LAD
LAD LAD
Case 1: (A) Discrete narrowing in the LAD on CT (coronary CTA, arrows) and (E, F) an apical defect by perfusion imaging (CT-MPI, arrows) with (J) concordant ICA and an
FFR of 0.76. The color bar in A displays the myocardial blood flow range from normal (red) to low (green and blue). (B) The same patient had a second stenosis in the
LCX, with (E, F) a posterolateral perfusion defect (arrowheads), concordant with (K) ICA and FFR of 0.74. Case 2: (C) Diffuse, partially calcified narrowing and focal
dilatation in the LAD on coronary CTA and a (G) CT-MPI perfusion defect in the distal septum and apex, confirmed by (L) ICA and an FFR of 0.56. Case 3: (D) Coronary
CTA shows severely calcified plaque of uncertain angiographic stenosis severity in the LAD and a predominantly noncalcified severe stenosis in a large Dg. (H) There is
a distinct anterolateral perfusion defect subtended by the Dg (arrow) but normal blood flow in the LAD territory. (M) ICA confirms the severe Dg stenosis (FFR: 0.68)
and functionally nonsignificant, moderate mid-LAD stenosis (FFR: 0.83). CT
¼ computed tomography; CT-MPI ¼ computed tomography myocardial perfusion imaging;
CTA ¼ computed tomography angiography; Dg ¼ diagonal branch; FFR ¼ fractional flow reserve; ICA ¼ invasive coronary angiography; LAD ¼ left anterior descending
coronary artery; LCX ¼ left circumflex coronary artery.
94% (95% CI: 91%-97%), and 88% (95% CI: 84%-92%), than coronary CTA with stenosis of $70% (94%; P <
respectively. Coronary CTA with CT-MPI demon- 0.05). However, the sensitivity of coronary CTA with
strated a higher specificity than coronary CTA CT-MPI was higher than that of coronary CTA for
stenosis of $50% (89% vs 72%; P < 0.001) but lower stenosis of $70% (84% vs 45%; P < 0.001) but lower
specificity
JACC: CARDIOVASCULAR IMAGING, VOL. 15, NO. 1, 2022 Nous et al 83
JANUARY 2022:75–87 Diagnostic Performance of Dynamic Perfusion CT
LCX
LCX
RCA
LAD
LAD
96%
Sensitivity 45%
84%
72%
Specificity 94%
89%
78%
Accuracy 82%
88%
CTA Stenosis ≥50% CTA Stenosis ≥70% CTA + Dynamic CT-MPI
Coronary computed tomography angiography(CTA) and invasive angiography demonstrating moderate stenosis (arrow) in the left anterior
descending coronary artery and severe stenosis (arrowhead) in the left circumflex coronary artery. Dynamic stress computed tomography
myocardial perfusion imaging demonstrated corresponding perfusion defects (yellow-blue) in the apex and lateral wall, indicating inducible
ischemia, as confirmed by fractional flow reserve. The bar graph below summarizes the diagnostic performance of CTA with a coronary
stenosis threshold of 50% and 70% to CTA combined with perfusion imaging.
alone. This study included centers with a range of prior QUANTITATIVE MBF ANALYSIS. Dynamic CT-MPI
CT-MPI experience but comparable technical and calculation of absolute MBF can be helpful in
performance, providing encouragement for broader multivessel disease with balanced ischemia or
clinical implementation. Invasive FFR and MPI are both microvascular disease (8,15,20). However, a challenge
functional tests, but each is based on different for dynamic CT-MPI is cardiac motion and myocardial
physiologic principles. Because of these mechanistic displacement during the long breath-hold (21).
differences, even a perfect perfusion test could not be Consequently, reported MBF cutoff values that
expected to exactly match the pressure drop over an signify hemodynamic significance vary substantially,
epicardial stenosis in every single patient. Coronary CTA from 75-164 mL/min/100 mL among studies (5,7-9).
at a low stenosis threshold is very sensitive but not very Therefore, several studies showed that MBF values
specific. Therefore, it is virtually unavoid- able that the normalized to remote myocardium outperform abso-
addition of CT-MPI, or other functional tests that
lute MBF values (20,22). However, more recent
improve specificity and overall accuracy, will
studies contradicted these findings (15,23), and also,
underestimate a number of lesions with an FFR of
in the present study, we observe no significant dif-
#0.80.
ference between absolute (AUC: 0.79) and relative
JACC: CARDIOVASCULAR IMAGING, VOL. 15, NO. 1, 2022 Nous et al 85
JANUARY 2022:75–87 Diagnostic Performance of Dynamic Perfusion CT
A
1.20
250.00
1.00
200.00
MBF
ml/min)
.80
Absolute
150.00
(ml/100
100.00 .60
50.00 .40
.00 .00
.00 .20 .40 .60 .80 1.00 .00 .20 .40 .60 .80 1.00
Invasive Fractional Flow Reserve Invasive Fractional Flow Reserve
B ** p = 0.007 ** p = 0.001
300.00 1.20
1.00
(ml/100 ml/min)
Absolute MBF
Relative MBF
200.00 .80
*
.60 *
*
100.00 .40
5
5
.7
.7
.20
≤0
≤0
0
.8
.8
.00 .00
-0
-0
76
76
1
1
.9
.9
0.
0.
5
5
.8
.8
≥0
≥0
-0
-0
81
81
0.
0.
0
-0
86
86
0.
0.
(A) Scatterplots comparing absolute (left) and relative (right) MBF with FFR with a correlation of 0.51 and 0.53, respectively. Horizontal and
vertical lines are placed at the cutoff values of absolute MBF, relative MBF, and FFR. (B) Boxplots show median values (IQR) of absolute (left)
and relative MBF (right). *P value from Kruskal-Wallis test. **P value from Mann-Whitney U test. FFR ¼ fractional flow reserve;
MBF ¼ myocardial blood flow.
REFERENCES
1. Douglas PS, Hoffmann U, Patel MR, et al. Out-
comes of anatomical versus functional testing for dynamic CT-based myocardial perfusion imaging. generation dual-source CT. 2020;21:58–67.
Korean J Radiol.
coronary artery disease. N Engl J Med. 2015;372: Radiology. 2011;260:689–698.
11. Mahnken AH, Klotz E, Pietsch H, et al. Quan-
1291–1300. 6.Rossi A, Merkus D, Klotz E, Mollet N, de titative whole heart stress perfusion CT imaging as
2. Litt HI, Gatsonis C, Snyder B, et al. CT angiog- Feyter PJ, Krestin GP. Stress myocardial perfusion: noninvasive assessment of hemodynamics in cor-
raphy for safe discharge of patients with possible onary artery stenosis: preliminary animal experi-
imaging with multidetector CT. Radiology.
ence. Invest Radiol. 2010;45:298–305.
2014;270:25–46.
acute coronary syndromes. N Engl J Med. 7. Rossi A, Dharampal A, Wragg A, et al. Diagnostic 12. Ebersberger U, Marcus RP, Schoepf UJ, et al.
2012;366:1393–1403. performance of hyperaemic myocardial blood flow Dynamic CT myocardial perfusion imaging: per-
3. Fihn SD, Blankenship JC, Alexander KP, et al. index obtained by dynamic computed tomogra- formance of 3D semi-automated evaluation soft-
phy: does it predict functionally significant coro- ware. Eur Radiol. 2014;24:191–199.
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused
nary lesions? Eur Heart J Cardiovasc Imaging. 13. Cerqueira MD, Weissman NJ, Dilsizian V, et al.
update of the guideline for the diagnosis and
2014;15:85–94.
management of patients with stable ischemic 8. Wang Y, Qin L, Shi X, et al. Adenosine-stress
heart disease: a report of the American College of
Cardiology/American Heart Association Task Force Standardized myocardial segmentation and
on Practice Guidelines, and the American Associ- dynamic myocardial perfusion imaging with nomenclature for tomographic imaging of the
ation for Thoracic Surgery, Preventive Cardiovas- second-generation dual-source CT: comparison heart. A statement for healthcare professionals
for
cular Nurses Association, Society with conventional catheter coronary angiography from the Cardiac Imaging Committee of
Cardiovascular Angiography and
Interventions, and SPECT nuclear myocardial perfusion imaging. the Council on Clinical Cardiology of the Amer-
and Society of Thoracic Surgeons. J Am Coll Car- AJR Am J Roentgenol. 2012;198:521–529. ican Heart Association. Circulation. 2002;105:
diol. 2014;64:1929–1949. 9. Pontone G, Baggiano A, Andreini D, et al. Dy- 539–542.
4.George RT, Mehra VC, namic stress computed tomography perfusion 14. Leipsic J, Abbara S, Achenbach S, et al. SCCT
al. Chen MY, et with a whole-heart coverage scanner in addition to guidelines for the interpretation and reporting of
Myocardial CT perfusion imaging and SPECT for coronary computed tomography angiography and coronary CT angiography: a report of the Society
the diagnosis of coronary artery disease: a head- fractional flow reserve computed tomography of Cardiovascular Computed Tomography Guide-
to-head comparison from the CORE320 Multi- derived. J Am Coll Cardiol Img. 2019;12:2460– lines Committee. J Cardiovasc Comput Tomogr.
center Diagnostic Performance Study. Radiology. 2471. 2014;8:342–358.
2014;272(2):407–416. 15. Rossi A, Wragg A, Klotz E, et al. Dynamic
10.Takafuji M, Kitagawa K,
5. Bamberg F, Becker A, Schwarz F, et al. Detec- computed tomography myocardial perfusion im-
tion of hemodynamically significant coronary ar- Ishida M, et al. aging: comparison of clinical analysis methods for
Myocardial coverage and radiation dose in dy-
tery stenosis: incremental diagnostic value of namic myocardial perfusion imaging using third-